Official ESCRS | European Society of Cataract & Refractive Surgeons
Copenhagen 2016 Registration Programme Exhibitor Information Virtual Exhibition Satellite Meetings Glaucoma Day 2016 Hotel Star Alliance
title

10 - 14 Sept. 2016, Bella Center, Copenhagen, Denmark

This Meeting has been awarded 27 CME credits

 

escrs app advert yo advert

Scleral-fixated and iris-claw intraocular lenses: long-term visual outcomes

Search Title by author or title

Session Details

Session Title: Cataract Surgery Complications/Management

Session Date/Time: Monday 12/09/2016 | 16:30-18:15

Paper Time: 17:38

Venue: Auditorium C6

First Author: : J.Cardigos PORTUGAL

Co Author(s): :    A. Basilio   L. Costa   B. Carvalho   A. Vicente   N. Marques   J. Feijao     

Abstract Details

Purpose:

To compare the long-term visual outcomes and safety of scleral-fixated posterior chamber and anterior chamber iris-claw intraocular lenses (IOLs) implantation.

Setting:

Central Lisbon Hospital Center, Ophthalmology Department

Methods:

Medical records of 7 eyes of 7 consecutive patients who had scleral-fixated posterior chamber IOL implantation and 10 eyes of 9 consecutive patients with anterior chamber iris-claw IOL implantation between 2009 and 2014, with more than 1 year of follow-up were retrospectively analyzed. Indication for IOL implantation was aphakia after cataract extraction and trauma. Demographic data, best corrected visual acuity (BCVA) previous and after surgery and complications during the follow-up period were studied.

Results:

There were no intraoperative complications. Patients submitted to scleral-fixated IOL implantion had a mean pre-operative VA of 0.7logMAR and pos-operative of 0.3logMAR (mean VA increase of 0.6logMAR). Patients submitted to iris-claw IOL implantation had a mean pre-operative VA of 0.8logMAR and post-operative of 0.2logMAR (mean VA increase of 0.3logMAR). Follow-up was secured in average 5.4 years and all IOLs are well fixated and stable. 6 of the 17 eyes had a pos-operative complication, including high intraocular pressure and cystoid macular oedema, that were managed with topical therapy. 1 eye with iris-claw IOL implantation had a desenclavated lens haptic.

Conclusions:

Scleral-fixated and iris-claw IOLs implantation provide good visual rehabilitation of aphakic eyes without capsular support. In most of the cases, there is an improvement in BCVA after surgery, but anterior chamber iris-claw IOL may entail superior visual outcomes. The choice of surgery procedure is dependent to surgeon experience and eye's conditions.

Financial Disclosure:

NONE

Back to previous